Lite Strategy CEO’s $0 Option Exercise Signals Insider Confidence on Low-Valued Biotech
Lite Strategy insider Justin J. exercises 455k options at $0, signaling confidence amid a volatile biotech market and hinting at long‑term upside for investors.
3 minutes to read